Search Results - "Chih-Kuo Tseng"
-
1
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Published in Liver international (01-12-2016)“…Background & Aims Oral antiviral therapy may reduce the disease progression of chronic hepatitis B (CHB) patients. We aimed to further investigate the efficacy…”
Get full text
Journal Article -
2
Moderate Risk of Hepatitis B Virus Reactivation in HBsAg−/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis
Published in Scientific reports (12-02-2020)“…To investigate the incidence and risk factors of hepatitis B virus (HBV) reactivation in HBV surface antigen (HBsAg) − / HBV core antibody (HBcAb) + patients…”
Get full text
Journal Article -
3
Risk of Hepatitis B Virus Reactivation in Rheumatoid Arthritis Patients Undergoing Tocilizumab-Containing Treatment
Published in Digestive diseases and sciences (01-11-2021)“…Background and Aim To investigate the risk of hepatitis B virus reactivation in patients undergoing long-term tocilizumab therapy for rheumatoid arthritis…”
Get full text
Journal Article -
4
HBV reactivation in HBsAg−/HBcAb+ rheumatoid arthritis patients receiving biologic/targeted synthetic DMARDs
Published in Liver international (01-02-2024)“…Background Rheumatoid arthritis (RA) patients seropositive for hepatitis B core antibody (HBcAb) and negative for hepatitis B surface antigen (HBsAg) are at…”
Get full text
Journal Article -
5
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
Published in Gut (01-01-2022)“…Data regarding the real-world effectiveness and safety of sofosbuvir/velpatasvir (SOF/VEL) with or without low-dose ribavirin (RBV) in patients with chronic…”
Get more information
Journal Article -
6
Characteristics of regulatory T‐cell function in patients with chronic hepatitis B and C coinfection
Published in Journal of viral hepatitis (01-08-2020)“…Regulatory T cells (Tregs) affect the pathogenesis and disease progression of chronic viral hepatitis. This study evaluated the frequency and function of Tregs…”
Get full text
Journal Article -
7
Neutrophil gelatinase-associated lipocalin partly reflects the dynamic changes of renal function among chronic hepatitis C patients receiving direct-acting antivirals
Published in PloS one (26-08-2021)“…Changes in renal function in chronic hepatitis C (CHC) patients receiving direct-acting antivirals (DAAs) are controversial. The evolution of neutrophil…”
Get full text
Journal Article -
8
Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
Published in BMC infectious diseases (09-04-2022)“…Hepatitis B virus (HBV) biomarkers reflect the status of HBV infection; however, their role in patients with chronic hepatitis B and C (HBV/HCV) coinfection…”
Get full text
Journal Article -
9
Regulatory T Cell Function Modulated After Successful Direct-Acting Antiviral Treatment for Chronic Hepatitis C Patients
Published in Digestive diseases and sciences (01-05-2020)“…Backgrounds Regulatory T cells (Tregs) affect the pathogenesis of chronic hepatitis C (CHC) infection. Aims This study evaluated the function of Tregs in CHC…”
Get full text
Journal Article -
10
The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma
Published in Journal of the Formosan Medical Association (01-03-2021)“…De novo and early recurrent hepatocellular carcinoma (HCC) have been observed in clinical practice after direct antiviral agents (DAA) treatment. The study…”
Get full text
Journal Article -
11
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort)
Published in Journal of gastroenterology and hepatology (01-10-2021)“…Background and Aim It is currently unknown how hepatitis C virus (HCV) eradication with pegylated interferon and ribavirin (PR) therapy affects the incidence…”
Get full text
Journal Article -
12
The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
Published in Viruses (01-08-2022)“…Hepatitis B and C (HBV/HCV) coinfected patients have a potential risk of hepatitis B reactivation (HBVr) after direct-acting antivirals (DAAs) treatment. The…”
Get full text
Journal Article -
13
Baseline thrombopoietin level is associated with platelet count improvement in thrombocytopenic chronic hepatitis C patients after successful direct-acting antiviral agent therapy
Published in BMC gastroenterology (21-01-2021)“…Thrombocytopenia can rapidly improve in chronic hepatitis C (CHC) patients receiving direct-acting antiviral agents (DAA). The role of baseline (BL)…”
Get full text
Journal Article -
14
Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan
Published in Hepatology international (01-04-2023)“…Background Real-world data are scarce about the effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir (SOF/VEL/VOX) for retreating East Asian…”
Get full text
Journal Article -
15
Factors predicting outcomes of hepatitis B-related cirrhosis patients with long-term antiviral therapy
Published in Journal of the Formosan Medical Association (01-10-2020)“…Long-term nucleos(t)ide analog (NA) therapy has been shown to improve the survival in patients with HBV-related cirrhosis. The aim of this study was to…”
Get full text
Journal Article -
16
Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan
Published in Journal of the Formosan Medical Association (01-05-2021)“…Radiofrequency ablation (RFA) is increasingly being used instead of surgical resection for the treatment of hepatocellular carcinoma (HCC) tumor measuring…”
Get full text
Journal Article -
17
Long‐term risk of end‐stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan
Published in Journal of gastroenterology and hepatology (01-08-2021)“…Background and Aim Chronic hepatitis C virus (HCV) infection is associated with impaired renal function. The aim of this study is to explore the risk of and…”
Get full text
Journal Article -
18
Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial
Published in BMC cancer (28-03-2019)“…Hepatocellular carcinoma (HCC) accounts for 75-85% of primary liver cancers and is prevalent in the Asia-Pacific region. Till now, trans-arterial…”
Get full text
Journal Article -
19
Identification and management of contraindicated drug–drug interactions through pharmaceutical care programs: Experience in direct-acting antivirals therapy
Published in Journal of the Formosan Medical Association (01-01-2022)“…To investigate the impact of pharmaceutical care programs for the management of contraindicated drug–drug interactions (DDIs) in direct-acting antivirals…”
Get full text
Journal Article -
20
A High-Speed and Low-Breakdown-Voltage Silicon Avalanche Photodetector
Published in IEEE photonics technology letters (15-03-2014)“…A silicon avalanche photodetector with a low breakdown voltage of -6.78 V is demonstrated by narrowing down the intrinsic layer width of interdigitated p-i-n…”
Get full text
Journal Article